Hiroshima, Japan

Naoaki Morihara

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wakunaga Pharmaceutical Co., Ltd.. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoaki Morihara. Retrieved from https://idiyas.com/inventor/naoaki-morihara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Hiroshima, JP (2019)
  • Akitakata, JP (2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Naoaki Morihara: Innovator in Blood Flow Improvement and Antihypertensive Agents.

Introduction

Naoaki Morihara is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing safe and effective agents for improving blood flow and managing hypertension. With a total of 2 patents to his name, Morihara's work is recognized for its innovative approach to health solutions.

Latest Patents

Morihara's latest patents include a blood flow improver and an antihypertensive agent. The blood flow improver is designed to be safe and has a mild action, utilizing S-1-propenylcysteine or a salt thereof as its active ingredient. Similarly, the antihypertensive agent also features S-1-propenylcysteine or a salt thereof, ensuring a safe and mild effect for users.

Career Highlights

Morihara is associated with Wakunaga Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical innovations. His dedication to creating effective health solutions has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Morihara has collaborated with esteemed colleagues such as Mitsuyasu Ushijima and Yukihiro Kodera. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Naoaki Morihara's contributions to the pharmaceutical field through his patents on blood flow improvement and antihypertensive agents highlight his commitment to health innovation. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…